IRIS
GAMBA, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.591
AS - Asia 2.652
EU - Europa 2.108
SA - Sud America 321
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 74
OC - Oceania 6
Totale 8.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.517
CN - Cina 1.446
SG - Singapore 566
IE - Irlanda 445
UA - Ucraina 322
FI - Finlandia 259
HK - Hong Kong 233
BR - Brasile 221
DE - Germania 215
RU - Federazione Russa 212
VN - Vietnam 170
IT - Italia 154
GB - Regno Unito 133
SE - Svezia 122
FR - Francia 119
IN - India 50
BD - Bangladesh 43
CA - Canada 43
ZA - Sudafrica 42
AR - Argentina 36
PL - Polonia 35
IQ - Iraq 29
MX - Messico 20
NL - Olanda 20
BE - Belgio 19
JP - Giappone 16
CO - Colombia 15
EC - Ecuador 15
IR - Iran 15
ID - Indonesia 14
PK - Pakistan 12
ES - Italia 11
MU - Mauritius 10
VE - Venezuela 10
MA - Marocco 7
PE - Perù 7
CL - Cile 6
KE - Kenya 6
PY - Paraguay 6
SA - Arabia Saudita 6
TR - Turchia 6
AU - Australia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
LT - Lituania 5
PH - Filippine 5
AT - Austria 4
BH - Bahrain 4
CH - Svizzera 4
OM - Oman 4
UZ - Uzbekistan 4
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
JO - Giordania 3
LB - Libano 3
RO - Romania 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
DM - Dominica 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SM - San Marino 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
Totale 8.763
Salva come PNG Salva come JPEG
Città #
San Jose 529
Dublin 442
Chandler 431
Jacksonville 405
Nanjing 322
Singapore 306
Ashburn 295
Beijing 237
Hong Kong 227
Dallas 175
Boardman 148
Council Bluffs 117
Nanchang 117
Shenyang 92
Lawrence 89
Princeton 89
Changsha 88
Hebei 86
Wilmington 85
Lauterbourg 79
Los Angeles 79
Jiaxing 75
Helsinki 72
Ho Chi Minh City 61
Medford 61
Ann Arbor 59
Tianjin 58
Hangzhou 47
Moscow 39
Hanoi 37
Buffalo 35
Woodbridge 34
Johannesburg 33
New York 33
Milan 29
Munich 28
Shanghai 24
São Paulo 23
Des Moines 22
Orem 22
Santa Clara 21
Brussels 19
Warsaw 19
Redondo Beach 17
Verona 17
Brooklyn 16
Houston 16
Seattle 16
Turku 16
Chicago 15
Frankfurt am Main 15
Kunming 15
Jinan 14
Radomsko 14
San Francisco 14
Tokyo 14
Baghdad 13
Manchester 13
Toronto 13
Chennai 12
Poplar 12
Amsterdam 11
Denver 11
London 11
Mexico City 11
Montreal 11
Norwalk 11
Taizhou 11
Ningbo 10
Atlanta 9
Boston 9
Dhaka 9
Fairfield 9
Guangzhou 9
Leawood 9
Stockholm 9
Zhengzhou 9
Mumbai 8
Rio de Janeiro 8
Dearborn 7
Fuzhou 7
Haiphong 7
Phoenix 7
Rome 7
Auburn Hills 6
Da Nang 6
Guayaquil 6
Hải Dương 6
Quito 6
The Dalles 6
Biên Hòa 5
Curitiba 5
Falkenstein 5
Falls Church 5
Jeddah 5
New Delhi 5
Nuremberg 5
Washington 5
Zanjan 5
Bogotá 4
Totale 5.846
Salva come PNG Salva come JPEG
Nome #
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 169
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 151
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 146
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 144
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 135
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 135
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 133
An unconventional case of scurvy. 130
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 129
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 127
Clotting alterations in primary systemic amyloidosis. 124
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 122
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 122
Acquired von Willebrand syndrome in inflammatory bowel disease 121
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. 119
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 119
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 118
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 117
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. 117
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 116
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 115
La valutazione della qualità della vita e della artropatia nel paziente emofilico adulto. 114
Platelet-independent defect in hemostasis associated with sirolimus use 112
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 111
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 111
Castleman's disease with coagulation defect. A case report. 111
Mitral valve prolapse and prothrombotic risk factors in children and adolescents with migraine with aura and other idiopathic headaches 110
Renal diseases in haemophilic patients: pathogenesis and clinical management. 110
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 110
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 108
Valutazione dell'artropatia in soggetti affetti da emofilia. 108
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. 107
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 104
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 104
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 103
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 101
In vitro and in vivo effects of desmopressin on platelet function 101
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 100
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 99
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 98
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 98
Homocysteine, vitamin b12 and folic acid levels in psoriasi patients and correlation with disease severity. 98
Performance in sports of children and adolescents with hereditary bleeding disorders 97
Liver damage and homocysteine plasma levels in haemophilia 96
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 96
Clotting alterations in primary systemic amyloidosis 95
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 95
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 94
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 94
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 94
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 93
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 93
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 93
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 91
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 90
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 90
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 90
Platelet function after in vivo and in vitro treatment with thrombolytic agents 90
Bleeding tendency of unknown origin and protein Z levels. 90
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 89
Desmopressin and platelets: In vitro and in vivo studies 88
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 88
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 88
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 87
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 85
Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage. 84
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. 83
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 81
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 80
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 80
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 79
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 77
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 75
Homocysteine and liver steatosis in HCV infected haemophiliacs 75
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study 75
Preoperative bleeding risk assessment with ISTH-BAT and laboratory tests in patients undergoing elective surgery: A prospective cohort study 74
Expression of dipeptidylaminopeptidase IV-CD26 in circulating lymphocytes of homophilic subjects 74
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 72
HEPARIN INFUSION FACILITATES PLATELETS ACTIVABILITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO HAVE UNDERGONE THROMBOLYTIC THERAPY 72
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 71
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 70
Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by agnogenic myeloid metaplasia 69
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 69
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 67
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 67
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 67
Interobserver reliability of ultrasound assessment of haemophilic arthropathy: Radiologist vs. non-radiologist 65
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 65
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 58
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. 53
Totale 8.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.784
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022406 0 0 13 9 3 10 13 20 33 13 50 242
2022/20231.270 146 85 2 111 148 137 0 62 508 17 35 19
2023/2024363 67 51 18 31 48 81 0 34 5 10 14 4
2024/20251.070 15 97 25 33 21 47 21 78 269 29 139 296
2025/20262.981 233 202 295 347 322 125 706 123 224 191 157 56
2026/2027147 44 103 0 0 0 0 0 0 0 0 0 0
Totale 8.835